Tag: SYNT001
Alexion to acquire Boston-based Syntimmune in $1.2bn deal
Alexion acquisition of Syntimmune : US pharma company Alexion Pharmaceuticals has signed a deal of around $1.2 billion to acquire Syntimmune, a Boston-based clinical-stage biotech ... Read More